Cargando…
Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction
Serine-threonine protein kinases are critical to CNS function, yet there is a dearth of highly selective, CNS-active kinase inhibitors for in vivo investigations. Further, prevailing assumptions raise concerns about whether single kinase inhibitors can show in vivo efficacy for CNS pathologies, and...
Autores principales: | Watterson, D. Martin, Grum-Tokars, Valerie L., Roy, Saktimayee M., Schavocky, James P., Bradaric, Brinda Desai, Bachstetter, Adam D., Xing, Bin, Dimayuga, Edgardo, Saeed, Faisal, Zhang, Hong, Staniszewski, Agnieszka, Pelletier, Jeffrey C., Minasov, George, Anderson, Wayne F., Arancio, Ottavio, Van Eldik, Linda J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694096/ https://www.ncbi.nlm.nih.gov/pubmed/23840427 http://dx.doi.org/10.1371/journal.pone.0066226 |
Ejemplares similares
-
Targeting Human Central Nervous System Protein Kinases:
An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease
Progression in Alzheimer’s Disease Mouse Models
por: Roy, Saktimayee M., et al.
Publicado: (2015) -
A Selective and
Brain Penetrant p38αMAPK Inhibitor
Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates
Neuroinflammation and Cognitive Dysfunction
por: Roy, Saktimayee M., et al.
Publicado: (2019) -
Correction to “A
Selective and Brain Penetrant
p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric
Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction”
por: Roy, Saktimayee M., et al.
Publicado: (2020) -
Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)
por: Bachstetter, Adam D, et al.
Publicado: (2011) -
Target Engagement Analysis and Link to Pharmacodynamic Endpoint for a Novel Class of CNS-penetrant and Efficacious p38α MAPK Inhibitors
por: Bachstetter, Adam D., et al.
Publicado: (2014)